Swissmedic news highlights April 2026

From the Swissmedic newsfeed, Arex Advisor has selected the most important regulatory updates from the past month. 

Swissmedic publishes FAQs on risk management for medicines

1 April 2026
Swissmedic has introduced a new set of frequently asked questions covering key requirements and procedures for the risk management of human medicinal products. The resource complements existing guidance, providing clearer, structured support for companies managing safety risks throughout a product’s lifecycle. Read more

How do these changes affect you?

Our experienced specialists are ready to help you navigate the regulatory landscape!

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.